Delivery Order SPE2D021DA002-SPE2D325F218P
Award Date
7/15/25
Potential Completion Date
7/18/25
Potential Value
$1.6K
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of 4568794629 PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML medical supplies. The contract has a completion date of July 18, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,132.00, is for the delivery of 4567916212 - PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML to support the medical supply needs of military health facilities. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. also holds a...
This is a $3,210.30 firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of 4,568,794,618 units of the pharmaceutical product PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML. The contract has a period of performance through July 18, 2025 and was awarded on July 15, 2025. DMS Pharmaceutical Group Inc. is an experienced federal contractor,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4567916216 - Procainamide 1 Gram/10 ML Vial 10 ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The contract has a ceiling value of $3,132.00 and an ultimate completion date of April 3, 2025. DMS Pharmaceutical Group Inc. also holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,155.02, is for the delivery of Procainamide 1 gram/10 ml vial (10 ml) to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,776.50 contract is for the delivery of 4,558,205,554 vials of 1 gram/10 ml procainamide, a prescription medication. The award is part of a larger single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4562048894 - Procainamide 1 Gram/10 ML Vial 10ML. The contract has a ceiling value of $1,530.61 and an ultimate completion date of August 21, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which supports the recurring...
This federal contract award, with ID SPE2DB20D6037|SPE2DB24FTXA8, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Procainamide 1 gram/10 ml vials with a ceiling value of $2,456.39. This delivery order contract is firm fixed-price and does not have a set-aside designation. The award is associated with a larger indefinite delivery contract (IDC) vehicle, valued up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,277.81 contract is for the delivery of Procainamide Hydrochloride, a pharmaceutical product, with a completion date of December 13, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a $1,265.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the pharmaceutical product Procainamide 1,000 mg/10 ml syringe, 10 ml. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price...